Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to shield identities of lethal‑injection suppliers over FOIA concerns
Summary
The committee approved SB 464, which expands secrecy around lethal‑injection drug suppliers and makes disclosure a felony; opponents warned of litigation, black‑market risks and First Amendment problems while the Attorney General defended the measure.
Senate Bill 464, presented by Sen. Hester, would expand statutory secrecy for the identities and supply chain of lethal‑injection drugs and create a class‑D felony for reckless disclosure. The committee heard pointed opposition from open‑government advocates and public‑health commentators but advanced the bill on a roll call vote, 5–3.
Supporters, including the Attorney General’s office, framed the bill as a practical response to earlier procurement disputes and Supreme…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
